Working… Menu

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03126227
Recruitment Status : Completed
First Posted : April 24, 2017
Last Update Posted : August 20, 2019
Information provided by (Responsible Party):
Aimmune Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 31, 2018
Actual Study Completion Date : September 23, 2018
Certification/Extension First Submitted : August 16, 2019